Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yang Cao, Xin Xie, Mingzhu Li & Yuhua Gao. (2021) CircHIPK2 Contributes to DDP Resistance and Malignant Behaviors of DDP-Resistant Ovarian Cancer Cells Both in vitro and in vivo Through circHIPK2/miR-338-3p/CHTOP ceRNA Pathway. OncoTargets and Therapy 14, pages 3151-3165.
Read now
Read now
Mingzhe Zhu, Lei Yang & Xin Wang. (2020) NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis. Cancer Management and Research 12, pages 7277-7289.
Read now
Read now
Yiyi Zhan, Kahaerjiang Abuduwaili, Xiuli Wang, Yanli Shen, Saiteer Nuerlan & Chunling Liu. (2020) Knockdown of Long Non-Coding RNA HOTAIR Suppresses Cisplatin Resistance, Cell Proliferation, Migration and Invasion of DDP-Resistant NSCLC Cells by Targeting miR-149-5p/Doublecortin-Like Kinase 1 Axis. Cancer Management and Research 12, pages 7725-7737.
Read now
Read now
P. Chanphai, V. Ouellette, S. Mandal, S. K. Mandal, G. Bérubé & H. A. Tajmir-Riahi. (2019) Location of multiple binding sites for testo and testo–Pt(II) with tRNA. Journal of Biomolecular Structure and Dynamics 37:16, pages 4133-4139.
Read now
Read now
Articles from other publishers (46)
Fei Li, Zaosong Zheng, Wei Chen, Dongqing Li, Henghui Zhang, Yuanchao Zhu, Qixin Mo, Xinlei Zhao, Qin Fan, Fan Deng, Conghui Han & Wanlong Tan. (2023) Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resistance Updates 68, pages 100938.
Crossref
Crossref
Berenice Cuevas-Estrada, Michel Montalvo-Casimiro, Paulina Munguia-Garza, Juan Alberto Ríos-Rodríguez, Rodrigo González-Barrios & Luis A. Herrera. (2023) Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients. International Journal of Molecular Sciences 24:9, pages 7873.
Crossref
Crossref
Faezeh Tolue Ghasaban, Amirhosein Maharati, Iman Akhlaghipour & Meysam Moghbeli. (2023) MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells. Cancer Cell International 23:1.
Crossref
Crossref
Sheng Li, Ming Jiang, Lin Yang, Fucun Zheng, Jiahao Liu, Xiong Situ, Xiaoqiang Liu, Liu Weipeng & Bin Fu. (2023) Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer. Frontiers in Genetics 14.
Crossref
Crossref
Zheng-Dong Luo, Yi-Feng Wang, Yu-Xiao Zhao, Long-Chen Yu, Tian Li, Ying-Jing Fan, Shun-Jie Zeng, Yan-Li Zhang, Yi Zhang & Xin Zhang. (2023) Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. World Journal of Gastroenterology 29:1, pages 1-18.
Crossref
Crossref
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida & Stavroula Baritaki. (2022) Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 65, pages 100866.
Crossref
Crossref
Eunji Kang, Kanggeon Kim, Sook Young Jeon, Ji Gwang Jung, Hong-Kyu Kim, Han-Byoel Lee & Wonshik Han. (2022) Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway. Cancer Gene Therapy 29:8-9, pages 1168-1180.
Crossref
Crossref
Zhigang Bai, Dongli Zhang & Enhong Shi. (2022) Long non-coding RNA opa-interacting protein 5 antisense transcript 1 (LncRNA OIP5-AS1) promoted cisplatin resistance in nasopharyngeal carcinoma via the miR-378a-3p/nicotinamide N-methyltransferase axis. Materials Express 12:7, pages 980-987.
Crossref
Crossref
Manjima Chatterjee & Sonali Sengupta. (2022) Human satellite III long noncoding RNA imparts survival benefits to cancer cells. Cell Biology International 46:4, pages 611-627.
Crossref
Crossref
Kirill E Medvedev, Anna V Savelyeva, Kenneth S Chen, Aditya Bagrodia, Liwei Jia & Nick V Grishin. (2022) Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis. Cancer Informatics 21, pages 117693512211326.
Crossref
Crossref
Yingying Jiang, Haiyan Guo, Tong Tong, Fei Xie, Xing Qin, Xiaoning Wang, Wantao Chen & Jianjun Zhang. (2022) lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5. Molecular Therapy 30:1, pages 448-467.
Crossref
Crossref
Hongcheng Luo, Tingzhuang Yi, Deyou Huang, Xiaoping Chen, Xu Li, Qianquan Wan, Haineng Huang, Huadong Huang, Hongyu Wei, Ye Song, Tianshi Que, Rentong Hu, Huatuo Huang, Kunxiang Luo, Chuanyu Li, Chengjian Qin, Chuanhua Zheng, Chuanliu Lan, Wencheng Chen, Dan Zhou & Qisheng Luo. (2021) circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway. Molecular Therapy - Nucleic Acids 26, pages 1255-1269.
Crossref
Crossref
Yaseen Hussain, Lubna Islam, Haroon Khan, Rosanna Filosa, Michael Aschner & Saba Javed. (2021) Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects. Phytotherapy Research 35:12, pages 6514-6529.
Crossref
Crossref
Ahmad Movahedpour, Seyyed Hossein Khatami, Marjan Khorsand, Mahsa Salehi, Amir Savardashtaki, Seyedeh Habibeh Mirmajidi, Babak Negahdari, Nezhat Khanjani, Parisa Naeli, Omid Vakili & Mortaza Taheri-Anganeh. (2021) Exosomal noncoding RNAs: key players in glioblastoma drug resistance. Molecular and Cellular Biochemistry 476:11, pages 4081-4092.
Crossref
Crossref
Hui Hou, Rong Yu, Haiping Zhao, Hao Yang, Yuchong Hu, Yue Hu & Junmei Guo. (2021) LncRNA OTUD6B-AS1 Induces Cisplatin Resistance in Cervical Cancer Cells Through Up-Regulating Cyclin D2 via miR-206. Frontiers in Oncology 11.
Crossref
Crossref
Dilek Cansu Gurer, İpek Erdogan, Ulvi Ahmadov, Merve Basol, Osama Sweef, Gulcin Cakan-Akdogan & Bünyamin Akgül. (2021) Transcriptomics Profiling Identifies Cisplatin-Inducible Death Receptor 5 Antisense Long Non-coding RNA as a Modulator of Proliferation and Metastasis in HeLa Cells. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Han Sun, Ping Wu, Bao Zhang, Xia Wu & Weixu Chen. (2021) MCM3AP‑AS1 promotes cisplatin resistance in gastric cancer cells via the miR‑138/FOXC1 axis. Oncology Letters 21:3.
Crossref
Crossref
Ke Zhang, Hong Zhou, Bo Yan & Xuanping Cao. (2020) TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma. Cancer Cell International 20:1.
Crossref
Crossref
Ping Luo, Shugui Wu, Kaibao Ji, Xia Yuan, Hongmi Li, Jinping Chen, Yunfei Tian, Yang Qiu & Xiaoming Zhong. (2020) LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1. PLOS ONE 15:11, pages e0223035.
Crossref
Crossref
Eleonora A. Braga, Marina V. Fridman, Alexey A. Moscovtsev, Elena A. Filippova, Alexey A. Dmitriev & Nikolay E. Kushlinskii. (2020) LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms. International Journal of Molecular Sciences 21:22, pages 8855.
Crossref
Crossref
Dmitry S. Karpov, Pavel V. Spirin, Andrey O. Zheltukhin, Vera V. Tutyaeva, Olga L. Zinovieva, Evgenia N. Grineva, Vera A. Matrosova, George S. Krasnov, Anastasiya V. Snezhkina, Anna V. Kudryavtseva, Vladimir S. Prassolov, Tamara D. Mashkova & Nikolai A. Lisitsyn. (2020) LINC00973 Induces Proliferation Arrest of Drug-Treated Cancer Cells by Preventing p21 Degradation. International Journal of Molecular Sciences 21:21, pages 8322.
Crossref
Crossref
Wen-Xi Tan, Ge Sun, Meng-Yuan Shangguan, Zhi Gui, Yang Bao, Yu-Feng Li & Zan-Hui Jia. (2020) Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling. Scientific Reports 10:1.
Crossref
Crossref
Viktor Hlaváč, Petr Holý & Pavel Souček. (2020) Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450. Journal of Personalized Medicine 10:3, pages 108.
Crossref
Crossref
Abdelrahman M. Elsayed, Paola Amero, Salama A. Salama, Abdelaziz H. Abdelaziz, Gabriel Lopez-Berestein & Cristian Rodriguez-Aguayo. (2020) Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer. Cancers 12:9, pages 2406.
Crossref
Crossref
Rui Zhao, Xin Zhang, Yanli Zhang, Yaping Zhang, Yongmei Yang, Yue Sun, Xin Zheng, Ailin Qu, Yvette Umwali & Yi Zhang. (2020) HOTTIP Predicts Poor Survival in Gastric Cancer Patients and Contributes to Cisplatin Resistance by Sponging miR-216a-5p. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Anaïs Wambecke, Mohammad Ahmad, Bernard Lambert, Florence Joly, Laurent Poulain, Christophe Denoyelle & Matthieu Meryet-Figuiere. (2020) The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer. Gynecologic Oncology 156:3, pages 726-733.
Crossref
Crossref
Yanjiao Zhu, Yichuan Zhao, Siyao Dong, Lu Liu, Lin Tai & Yan Xu. (2020) Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types. Genomics 112:2, pages 1214-1222.
Crossref
Crossref
Shuping Zhou, Juan Wei, Yeliu Wang & Xinkuang Liu. (2020) Cisplatin resistance‑associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma. Experimental and Therapeutic Medicine.
Crossref
Crossref
Cecilie Abildgaard, Luisa M. Do Canto, Karina D. Steffensen & Silvia R. Rogatto. (2020) Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Yaqian Xu, Yan Wang, Chenwei Yuan, Xiaonan Sheng, Rui Sha, Huijuan Dai, Shan Zhang, Yaohui Wang, Yanping Lin, Liheng Zhou, Shuguang Xu, Jie Zhang, Wenjin Yin & Jinsong Lu. (2020) Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy. Therapeutic Advances in Medical Oncology 12, pages 175883592094088.
Crossref
Crossref
Yidi Qu, Hor-Yue Tan, Yau-Tuen Chan, Hongbo Jiang, Ning Wang & Di Wang. (2020) The functional role of long noncoding RNA in resistance to anticancer treatment. Therapeutic Advances in Medical Oncology 12, pages 175883592092785.
Crossref
Crossref
Xingkang Jiang, Shanqi Guo, Yangyi Zhang, Yang Zhao, Xiaojiang Li, Yingjie Jia, Yong Xu & Baojie Ma. (2020) LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p. Cellular Signalling 65, pages 109422.
Crossref
Crossref
Min Hu, Qi Zhang, Xiao‐Hui Tian, Jin‐Lin Wang, Ya‐Xuan Niu & Gang Li. (2019) lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR‐143/PLK1/BUBR1 axis. Molecular Carcinogenesis 58:12, pages 2207-2217.
Crossref
Crossref
Xianfang Wang, Jun Shi, Ying Chen, Caihong Wang, Huifang Shi & Xuefang Xie. (2019) Retracted Article: Long noncoding RNA ANRIL knockdown increases sensitivity of non-small cell lung cancer to cisplatin by regulating the miR-656-3p/SOX4 axis. RSC Advances 9:66, pages 38735-38744.
Crossref
Crossref
Laura Moreno Leon, Marine Gautier, Richard Allan, Marius Ilié, Nicolas Nottet, Nicolas Pons, Agnes Paquet, Kévin Lebrigand, Marin Truchi, Julien Fassy, Virginie Magnone, Garrett Kinnebrew, Milan Radovich, Meyling Hua-Chen Cheok, Pascal Barbry, Georges Vassaux, Charles-Hugo Marquette, Gilles Ponzio, Mircea Ivan, Nicolas Pottier, Paul Hofman, Bernard Mari & Roger Rezzonico. (2019) The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress. Oncogene 38:46, pages 7146-7165.
Crossref
Crossref
Hongde Zhang, Yi Luo, Wenli Xu, Kang Li & Changzheng Liao. (2019) Silencing long intergenic non‑coding RNA 00707 enhances cisplatin sensitivity in cisplatin‑resistant non‑small‑cell lung cancer cells by sponging miR‑145. Oncology Letters.
Crossref
Crossref
Xiang Song, Chao Zhang, Zhaoyun Liu, Qi Liu, Kewen He & Zhiyong Yu. (2019) Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer. PeerJ 7, pages e7522.
Crossref
Crossref
Chao-Yue Sun, Juan Nie, Jie-Peng Huang, Guang-Juan Zheng & Bing Feng. (2019) Targeting STAT3 inhibition to reverse cisplatin resistance. Biomedicine & Pharmacotherapy 117, pages 109135.
Crossref
Crossref
Hui Chang, Guan‐Nan Wang & Ya‐Lan Tao. (2019) The expression of long noncoding RNA CRCAL‐3 in colorectal cancer and its impacts on cell proliferation and migration. Journal of Cellular Biochemistry 120:9, pages 15369-15377.
Crossref
Crossref
Tongbao Feng, Ping Zhang, Yingxin Sun, Yan Wang, Jichun Tong, Hong Dai & Zichun Hua. (2019) High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation. Gene 710, pages 258-264.
Crossref
Crossref
Wenyuan Zhao, Yuanqi Liu, Chunfang Zhang & Chaojun Duan. (2019) Multiple Roles of Exosomal Long Noncoding RNAs in Cancers. BioMed Research International 2019, pages 1-12.
Crossref
Crossref
Hongda Ding, Junpeng Liu, Ruoyao Zou, Pengrui Cheng & Yang Su. (2019) RETRACTED ARTICLE: Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Liangfeng Chen, Xiaobing Han, Zhongzhou Hu & Liangxin Chen. (2019) The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis. Cancer Chemotherapy and Pharmacology 83:5, pages 921-931.
Crossref
Crossref
Hui Zhou, Yabin Ma, Dequan Zhong & Li Yang. (2019) Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204. Biomedicine & Pharmacotherapy 112, pages 108633.
Crossref
Crossref
Chao-Yue Sun, Qian-Yu Zhang, Guang-Juan Zheng & Bing Feng. (2019) Phytochemicals: Current strategy to sensitize cancer cells to cisplatin. Biomedicine & Pharmacotherapy 110, pages 518-527.
Crossref
Crossref
Hao Wang, Lei Fang, Jing Jiang, Ye Kuang, Beidi Wang, Xiumin Shang, Peilin Han, Yue Li, Meimei Liu, Zongfeng Zhang & Peiling Li. (2018) The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation. Cell Death & Disease 9:11.
Crossref
Crossref